Cargando…
Demyelination in Mild Cognitive Impairment Suggests Progression Path to Alzheimer’s Disease
The preclinical Alzheimer's disease (AD) - amnestic mild cognitive impairment (MCI) - is manifested by phenotypes classified into exclusively memory (single-domain) MCI (sMCI) and multiple-domain MCI (mMCI). We suggest that typical MCI-to-AD progression occurs through the sMCI-to-mMCI sequence...
Autores principales: | Carmeli, Cristian, Donati, Alessia, Antille, Valérie, Viceic, Dragana, Ghika, Joseph, von Gunten, Armin, Clarke, Stephanie, Meuli, Reto, Frackowiak, Richard S., Knyazeva, Maria G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758332/ https://www.ncbi.nlm.nih.gov/pubmed/24023644 http://dx.doi.org/10.1371/journal.pone.0072759 |
Ejemplares similares
-
Structural covariance of superficial white matter in mild Alzheimer's disease compared to normal aging
por: Carmeli, Cristian, et al.
Publicado: (2014) -
Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease
por: Zufferey, Valérie, et al.
Publicado: (2017) -
A multi-contrast MRI study of microstructural brain damage in patients with mild cognitive impairment
por: Granziera, C., et al.
Publicado: (2015) -
Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Carmeli, Cristian, et al.
Publicado: (2012) -
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study
por: Gantenbein, Andreas R, et al.
Publicado: (2021)